These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4257271)

  • 1. Molecular aspects of fibrin clot solubilization.
    Gaffney PJ
    Nat New Biol; 1971 Dec; 234(52):281-2. PubMed ID: 4257271
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHEMISTRY AND PHYSIOLOGY OF THE FIBRINOGEN-FIBRIN TRANSITION.
    LAKI K; GLADNER JA
    Physiol Rev; 1964 Apr; 44():127-60. PubMed ID: 14152903
    [No Abstract]   [Full Text] [Related]  

  • 4. BLOOD COAGULATION: PRACTICAL SIGNIFICANCE OF RECENT ADVANCES IN KNOWLEDGE OF PROTHROMBIN.
    SEEGERS WH
    Tex State J Med; 1963 Nov; 59():1068-75. PubMed ID: 14084901
    [No Abstract]   [Full Text] [Related]  

  • 5. THE BINDING OF HUMAN FIBRINOGEN TO NATIVE AND FRACTION FIBRINS AND THE INHIBITION OF POLYMERIZATION OF A NEW HUMAN FIBRIN MONOMER BY FIBRINOGEN.
    COPLEY AL; LUCHINI BW
    Life Sci (1962); 1964 Nov; 3():1293-305. PubMed ID: 14231779
    [No Abstract]   [Full Text] [Related]  

  • 6. Properties of thrombin and fibrinolysin lysed fibrin.
    Triantaphyllopoulos DC; Muirhead CR; Triantaphyllopoulos E
    Thromb Diath Haemorrh Suppl; 1969; 36():269-76. PubMed ID: 5375545
    [No Abstract]   [Full Text] [Related]  

  • 7. [Structure and function of fibrinogen].
    Iwanaga S
    Tanpakushitsu Kakusan Koso; 1969 Mar; 14(3):175-95. PubMed ID: 4240151
    [No Abstract]   [Full Text] [Related]  

  • 8. SOLUBILITY OF FIBRIN CLOTS IN SOLUTIONS OF HEPARIN.
    TRIANTAPHYLLOPOULOS DC; TRIANTAPHYLLOPOULOS E
    Nature; 1964 Dec; 204():1096-8. PubMed ID: 14243392
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors affecting plasma clot absorbance and fibrin mass.
    Rosenfeld L
    Clin Chim Acta; 1967 Oct; 18(1):1-10. PubMed ID: 6064688
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modern data on the chemistry and physiology of fibrinogen].
    Andreenko GV
    Usp Sovrem Biol; 1974; 77(1):51-69. PubMed ID: 4282801
    [No Abstract]   [Full Text] [Related]  

  • 11. VARIABILITY OF THE ANTICOAGULANT FRACTION OF INCUBATED FIBRINOGEN.
    TRIANTAPHYLLOPOULOS E; TRIANTAPHYLLOPOULOS DC
    Am J Physiol; 1965 Mar; 208():521-7. PubMed ID: 14264744
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin].
    Kudriashov BA; Liapina LA; Molchanova LV; Rustamova BA
    Vopr Med Khim; 1970; 16(2):161-8. PubMed ID: 4247358
    [No Abstract]   [Full Text] [Related]  

  • 13. Formation of highly ordered polymers from fibrinogen and fibrin degradation products.
    Niewiarowski S; Stewart GJ; Marder VJ
    Biochim Biophys Acta; 1970 Nov; 221(2):326-41. PubMed ID: 4249928
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equilibria in the fibrinogen--fibrin conversion. 8. Polymerization of acceptor-modified fibrin monomer.
    Endres GF; Scheraga HA
    Biochemistry; 1968 Dec; 7(12):4219-26. PubMed ID: 5750166
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrinogen and fibrin degradation products].
    Fujimaki M; Ikematsu S; Kato M
    Rinsho Byori; 1973 Jan; 21(1):31-6. PubMed ID: 4267650
    [No Abstract]   [Full Text] [Related]  

  • 17. Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
    Helms CC; Kapadia S; Gilmore AC; Lu Z; Basu S; Kim-Shapiro DB
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):356-364. PubMed ID: 27755019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Thrombin within fibrin clots: inactivation of thrombin by antithrombin-III.
    Naski MC; Shafer JA
    Thromb Res; 1993 Mar; 69(5):453-65. PubMed ID: 8497860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin activity of fibrin thrombi and soluble plasmic derivatives.
    Francis CW; Markham RE; Barlow GH; Florack TM; Dobrzynski DM; Marder VJ
    J Lab Clin Med; 1983 Aug; 102(2):220-30. PubMed ID: 6223106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of fibrinogen derivatives used in clinical investigation.
    Soria J; Soria C; Mirshahi M; Samama MM
    Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.